Ophthalmology

San Diego Academy of Regenerative Therapies publishes article about first-in-human clinical trial using adipose-derived SVF to treat post-COVID-19 patients suffering lung damage

ADVM-022 demonstrates efficacy, durability in OPTIC trial in wet AMD

ProQR offers upbeat interim analysis in Phase 1/2 trial of QR-421a for Usher Syndrome

Ocugen’s gene therapy candidate shows potential in five different models of retinitis pigmentosa

Two new cell models for ocular drug discovery could reduce the need for animal testing

Adverum’s wet AMD candidate helps maintain vision in Phase 1 trial

Clearside announces option exercise by REGENXBIO for gene therapy delivery tech

A trio of companies report trial progression or positive data for AMD-targeted therapeutics

GenSight reports marked visual improvement in Phase 3 study of rare eye disease

Vector platform delivers gene therapy to the retina

RegeneRx partner receives patent for new ophthalmic formulation of thymosin beta 4

Mannin Research, Biointerfaces Institute to pursue GDF15 biomarker diagnostic for eye disease